US stock futures were steady in early Asian trade after a positive week on Wall Street. On Friday, in a shortened ...

The cosmetics and personal care segment remains the dominant end-use area, capturing 50.6% of market share in 2025.

Since November 2024, Fucaso has been accessible in Hong Kong through the Named Patient Programme (NPP). Following this approval, IASO Bio plans to expand its "Manufactured in Nanjing, Supplied ...

"We built real medicine while the industry chased loopholes," said Duane Boise, President and CEO of MMJ International Holdings. "We have a stabilized, standardized, and analytically verified ...

| Adopting an RTU vial setup for aseptic filling process can help optimize operational efficiency, reduce TCO, and comply ...

Hi-Tech Pharmaceuticals and CEO Jared Wheat were convicted of a $4.7 million fraud and money laundering scheme.

Exyte, a global leader in the design, engineering, and delivery of high-tech facilities, has completed the integration of ...

The Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, has witnessed the signing of a major ...

Sudeep Pharma’s Rs 895-crore IPO enters its final bidding day with strong overall demand, led by robust NII and retail ...

Seeing a facility's operations, production flow, and equipment layout enables InstantGMP to better understand customer challenges. This ensures system configurations are correct the first time, ...

Sudeep Pharma’s Rs 895-crore IPO has seen strong early interest, already oversubscribed on Day 1 with robust demand from ...

Alex Mitchell, Vice President, Operations, Sentry BioPharma Services, discusses the growing use of FTZs by pharmaceutical ...